期刊文献+

多黏菌素B联合舒巴坦钠治疗多重耐药革兰阴性菌定植或感染患者住院后继发感染的疗效

Efficacy of Polymyxin B Combined with Sulbactam Sodium in the Treatment of Secondary Infections in Patients with Multidrug-resistant Gram-negative Bacterial Colonization or Infection After Hospitalization
原文传递
导出
摘要 目的:探究多黏菌素B联合舒巴坦钠治疗多重耐药革兰阴性菌定植或感染患者住院后继发感染的疗效。方法:选取2020年1月—2024年6月在焦作市第三人民医院及徐州市第七人民医院ICU接受治疗的重症患者186例,按照治疗方法不同将患者随机分为多黏菌素B治疗组和对照组,每组93例。对照组给予注射用舒巴坦钠治疗,多黏菌素B治疗组采用舒巴坦钠联合多黏菌素B治疗。比较两组治疗总有效率、多重耐药革兰阴性菌清除率、住院时间及住院费用。结果:多黏菌素B治疗组治疗总有效率和多重耐药革兰阴性菌清除率分别为98.92%和97.85%,高于对照组的81.72%和73.12%,且多黏菌素B治疗组住院时间及住院费用低于对照组,差异均有统计学意义(P<0.05)。结论:多黏菌素B联合舒巴坦钠治疗可提高多重耐药革兰阴性菌定植或感染患者的效果,提高多重耐药革兰阴性菌清除率,同时缩短患者住院时间,减轻患者经济负担。 Objective:To explore the efficacy of polymyxin B combined with sulbactam sodium in the treatment of secondary infection in patients colonized or infected by multi-drug resistant gram-negative bacteria after hospitalization.Methods:A total of 186 critically ill patients treated in the ICU of the Jiaozuo Third People’s Hospital and Xuzhou Seventh People’s Hospital from January 2020 to June 2024 were selected and randomly divided into polymyxin B treatment group and control group according to different treatment methods,with 93 patients in each group.The control group was treated with sulbactam sodium for injection,and the polymyxin Bgroup was treated with sulbactam sodium combined with polymyxin B.The total effective rate,clearance rate of multi-drug resistant gram-negative bacteria,length of stay and hospitalization cost were compared between the two groups.Results:The total effective rate and clearance rate of multidrug-resistant gram-negative bacteria in polymyxin-E treatment group were 98.92%and 97.85%,respectively,which were higher than 81.72%and 73.12%in the control group,and the hospitalization time and hospitalization cost in polymyxin-E treatment group were lower than those in the control group,with statistical significance(P<0.05).Conclusion:Polymyxin B combined with sulbactam sodium can improve the efficacy of multidrug-resistant gram-negative bacteria colonized or infected patients,increase the clearance rate of multidrug-resistant gram-negative bacteria,shorten the hospital stay of patients,and reduce the economic burden of patients.
作者 程琰 陈楠 CHENG Yan;CHEN Nan(Department of Infectious Diseases,Jiaozuo Third People’s Hospital,Jiaozuo 454000,Henan,China;Beijing Ditan Hospital Xuzhou Hospital/Xuzhou Seventh People’s Hospital Postal,Xuzhou 221000,Jiangsu,China)
出处 《中国药物滥用防治杂志》 CAS 2024年第9期1680-1683,共4页 Chinese Journal of Drug Abuse Prevention and Treatment
基金 河南省医学科技攻关计划项目(编号:LHGJ202000136)。
关键词 多重耐药革兰阴性菌 继发感染 药物治疗 治疗效果 Multidrug resistant gram-negative bacteria Secondary infection Medication Therapeutic effect
  • 相关文献

参考文献1

  • 1胡付品,郭燕,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,黄颖,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,邹凤梅,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,郭大文,赵金英,喻华,黄湘宁,刘文恩,李艳明,金炎,邵春红,徐雪松,鄢超,王山梅,楚亚菲,张利侠,马娟,周树平,周艳,朱镭,孟晋华,董方,吕志勇,胡芳芳,沈瀚,周万青,贾伟,李刚,吴劲松,卢月梅,李继红,段金菊,康建邦,马晓波,郑燕萍,郭如意,朱焱,陈运生,孟青,王世富,胡雪飞,沈继录,汪瑞忠,房华,俞碧霞,赵勇,龚萍,温开镇,张贻荣,刘江山,廖龙凤,顾洪芹,姜琳,贺雯,薛顺虹,冯佼,岳春雷.2021年CHINET中国细菌耐药监测[J].中国感染与化疗杂志,2022,22(5):521-530. 被引量:104

二级参考文献5

  • 1王辉,俞云松,王明贵,倪语星,马越,任健康,韩锟,卓超,徐英春,胡云建,胡志东,曹彬,罗燕萍,褚云卓,廖康,康梅,张冀霞.替加环素体外药敏试验操作规程专家共识[J].中华检验医学杂志,2013,36(7):584-587. 被引量:134
  • 2胡付品,郭燕,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,黄颖,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,邹凤梅,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,郭大文,赵金英,喻华,黄湘宁,刘文恩,李艳明,金炎,邵春红,徐雪松,鄢超,王山梅,楚亚菲,张利侠,马娟,周树平,周艳,朱镭,孟晋华,董芳,郑红艳,胡芳芳,沈瀚,周万青,贾伟,李刚,吴劲松,卢月梅,李继红,段金菊,康建邦,马晓波,郑燕萍,郭如意,朱焱,陈运生,孟青.2019年CHINET三级医院细菌耐药监测[J].中国感染与化疗杂志,2020,20(3):233-243. 被引量:347
  • 3无,杨启文,马筱玲,胡付品,张菁,孙同文,陈佰义,徐英春,刘又宁.多黏菌素药物敏感性检测及临床解读专家共识[J].协和医学杂志,2020,11(5):559-570. 被引量:43
  • 4郑永贵,胡付品,朱德妹,郭燕,杨洋,董栋,吴湜,汪瑞忠,房华,俞碧霞,赵勇,龚萍,温开镇,张贻荣,刘江山,廖龙凤,顾洪芹,姜琳,贺雯,薛顺虹,冯佼,窦睿,岳春雷.2019年CHINET细菌耐药监测网二级医院监测结果[J].中国感染与化疗杂志,2020,20(6):585-593. 被引量:48
  • 5喻华,徐雪松,李敏,杨启文,杨青,张嵘,褚云卓,单斌,郭大文,胡志东,简翠,李轶,廖康,刘根焰,季萍,金炎,倪语星,沈瀚,苏丹虹,卓超,王辉,魏莲花,俞云松,张泓,张利侠,周铁丽,朱镭,王明贵,朱德妹,胡付品.肠杆菌目细菌碳青霉烯酶的实验室检测和临床报告规范专家共识[J].中国感染与化疗杂志,2020,20(6):671-680. 被引量:102

共引文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部